Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses

Science Translational Medicine
Volume 14| Issue 634| 2 Mar 2022
https://www.science.org/toc/stm/current

 

Report
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses
BY Benjamin L. Sievers et al.